Managing Biotechnology by Françoise Simon & Glen Giovannetti

Author:Françoise Simon & Glen Giovannetti
Language: eng
Format: epub
Published: 2017-09-05T00:00:00+00:00

In conclusion, patient centricity is driven by a transformative culture and involves new models and processes at each stage of the value chain, as well as a comprehensive cross-functional and cross-regional coordination.

Summary Points

Patient centricity is a comprehensive mindset that integrates the consumer voice from discovery to post-approval; it connects the points of care and aims to create a seamless system, from patient-generated data to medical offices and health delivery organizations.

Patient centricity is driven by multiple scientific and market forces, from regulator interest in patient-reported outcomes to digital technologies enabling consumers to track their health, payer demand for real-word evidence to show value, and the growing power of patient communities, especially in rare diseases.

Barriers remain, from legal restrictions on biopharma/patient communications to the limited functionality of wearables, privacy and security issues, and the weak evidence of the return on investment of patient engagement.

At the discovery stage, companies are codeveloping with patients prediction-focused platforms and engaging in crowdsourcing initiatives.

Clinical trials now largely include patient-reported outcomes, but these have not so far been broadly accepted for product approvals by regulators; collaborations with advocacy groups can optimize patient recruitment and retention.

Connecting the points of care is challenged by information gaps on prevention and disease awareness across global markets; patient satisfaction ratings are widespread but remain controversial, with weak correlation between surveys and quantitative ratings such as mortality and morbidity; consumer-generated online reviews are not structured or curated.

Physician/patient dynamics suffer from insufficient time for encounters but may be optimized by shared decision making, e-consultations, and digital education tools.

Biopharmas have greatly expanded patient collaborations but still suffer from public distrust and a lack of awareness of their support services.

Understanding the patient journey is key for product co-creation and entails extensive information, from the pre-diagnosis to post-treatment stages.

Patient engagement metrics remain a challenge but can benefit from patient experience tracking by advocacy groups as well as links with existing performance indicators.

Senior leadership commitment is key to creating a worldwide patient-centric culture; organization models include decentralization within business units, but they are trending toward centralization around chief patient officers with global responsibilities.

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.